同濟科技(600846.SH):子公司中標鳳南一村小區舊住房更新(拆除重建)項目工程
格隆匯5月17日丨同濟科技(600846.SH)公佈,公司全資子公司上海同濟建設有限公司收到上海衞百辛(集團)有限公司發出的中標通知書,上海同濟建設有限公司中標鳳南一村小區舊住房更新(拆除重建)項目工程。
該項目位於上海市楊浦區,東至黃興路,西至鳳城路,南至周家嘴路,北至控江路。該項目擬以拆除重建方式對鳳南一村小區實施成套改造,新建8幢住宅及變電站、垃圾房、門衞等配套設施,新建總建築面積約197,414.00平方米,其中地上建築面積131,134.18平方米,地下建築面積66,279.82平方米。該工程項目中標價格138,315.3271萬元,中標工期900日曆天。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.